The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Projected life expectancy of people with HIV according to timing of diagnosis
Abstract
BACKGROUND AND OBJECTIVES: Effective antiretroviral therapy (ART) has contributed greatly toward survival for people with HIV, yet many remain undiagnosed until very late. Our aims were to estimate the life expectancy of an HIV-infected MSM living in a developed country with extensive access to ART and healthcare, and to assess the effect of late diagnosis on life expectancy. METHODS: A stochastic computer simulation model of HIV infection and the effect of ART was used to estimate life expectancy and determine the distribution of potential lifetime outcomes of an MSM, aged 30 years, who becomes HIV positive in 2010. The effect of altering the diagnosis rate was investigated. RESULTS: Assuming a high rate of HIV diagnosis (median CD4 cell count at diagnosis, 432 cells/μl), projected median age at death (life expectancy) was 75.0 years. This implies 7.0 years of life were lost on average due to HIV. Cumulative risks of death by 5 and 10 years after infection were 2.3 and 5.2%, respectively. The 95% uncertainty bound for life expectancy was (68.0,77.3) years. When a low diagnosis rate was assumed (diagnosis only when symptomatic, median CD4 cell count 140 cells/μl), life expectancy was 71.5 years, implying an average 10.5 years of life lost due to HIV. CONCLUSION: If low rates of virologic failure observed in treated patients continue, predicted life expectancy is relatively high in people with HIV who can access a wide range of antiretrovirals. The greatest risk of excess mortality is due to delays in HIV diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., Vernazza, P., Sudre, P., Flepp, M., Furrer, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01122-8 · Cited by 906
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00003 · Cited by 748
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
The Survival Benefits of AIDS Treatment in the United States
Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/505147 · Cited by 581
Sterne, J. A., Hernán, M. A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., Rickenbach, M., Robins, J. M., & Egger, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67022-5 · Cited by 557
Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness
Paltiel, A. D., Weinstein, M. C., Kimmel, A. D., Seage, G. R., Losina, E., Zhang, H., Freedberg, K. A., & Walensky, R. P. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042088 · Cited by 553
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., Weinstein, M. C., Seage, G. R., Moore, R. D., & Freedberg, K. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000228021.89490.2a · Cited by 410
Lewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin, J.-L., Katlama, C., Dabis, F., & Leport, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318134257a · Cited by 402
Franco, O. H., Steyerberg, E. W., Hu, F. B., Mackenbach, J., & Nusselder, W. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1145 · Cited by 400
van Sighem, A., Gras, L., Reiss, P., Brinkman, K., & de Wolf, F. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3946 · Cited by 398
Herida, M., Mary-Krause, M., Kaphan, R., Cadranel, J., Poizot-Martin, I., Rabaud, C., Plaisance, N., Tissot-Dupont, H., Boue, F., Lang, J.-M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.096 · Cited by 339
Lima, V. D., Harrigan, R., Bangsberg, D. R., Hogg, R. S., Gross, R., Yip, B., & Montaner, J. S. G. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819675e9 · Cited by 304
The role of HIV in serious diseases other than AIDS.
Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269
Self-citationSevere Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Mommeja‐Marin, H., Hinkle, J., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 242
Harrison, K. M., Song, R., & Zhang, X. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b563e7 · Cited by 231
Chadborn, T. R., Delpech, V. C., Sabin, C. A., Sinka, K., & Evans, B. G. (2006) · AIDS · doi:10.1097/qad.0b013e32801138f7 · Cited by 223
Self-citationFang, C. T., Chang, Y. Y., Hsu, H. M., Twu, S. J., Chen, K. T., Lin, C. C., Huang, L. Y. L., Chen, M. Y., Hwang, J. S., Wang, J. D., et al. (2006) · QJM · doi:10.1093/qjmed/hcl141 · Cited by 163
Correlates of Lending Needles/Syringes Among HIV-Seropositive Injection Drug Users
Metsch, L. R., Pereyra, M., Purcell, D. W., Latkin, C. A., Malow, R., Gómez, C. A., & Latka, M. H. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181576818 · Cited by 158
UK CHIC Study Group The UK Collaborative Group on HIV Drug Resistance (2005) · AIDS · doi:10.1097/01.aids.0000162337.58557.3d · Cited by 151
Gill, V. S., Lima, V. D., Zhang, W., Wynhoven, B., Yip, B., Hogg, R. S., Montaner, J. S. G., & Harrigan, P. R. (2009) · Clinical Infectious Diseases · doi:10.1086/648729 · Cited by 140
Kovari, H., Ledergerber, B., Peter, U., Flepp, M., Jost, J., Schmid, P., Calmy, A., Mueller, N. J., Muellhaupt, B., Weber, R. K., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/603559 · Cited by 139
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy
Staszewski, S., Miller, V., Sabin, C. A., Schlecht, C., Gute, P., Stamm, S., Leder, T., Berger, A., Weidemann, E., Hill, A., et al. (1999) · AIDS · doi:10.1097/00002030-199905280-00011 · Cited by 138
Self-citationEstimating the proportion of patients infected with HIV who will die of comorbid diseases
Braithwaite, R. S., Justice, A. C., Chang, C. H., Fusco, J. S., Raffanti, S. R., Wong, J. B., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.034 · Cited by 136
HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction
Francisci, D., Giannini, S., Baldelli, F., Leone, M., Belfiori, B., Guglielmini, G., Malincarne, L., & Gresele, P. (2009) · AIDS · doi:10.1097/qad.0b013e328325a87c · Cited by 133
Cigarette smoking and mortality
Kuller, L. H., Ockene, J. K., Meilahn, E. N., Wentworth, D. N., Svendsen, K. H., & Neaton, J. D. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90060-h · Cited by 112
Virological rebound after suppression on highly active antiretroviral therapy
Mocroft, A., Ruiz, L., Reiss, P., Ledergerber, B., Katlama, C., Lazzarin, A., Goebel, F., Phillips, A. N., Clotet, B., & Lundgren, J. D. (2003) · AIDS · doi:10.1097/00002030-200308150-00003 · Cited by 107
Self-citationLampe, F. C., Gatell, J. M., Staszewski, S., Johnson, M. A., Pradier, C., Gill, M. J., de Lazzari, E., Dauer, B., Youle, M. S., Fontas, É., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.521 · Cited by 90
Self-citationLong-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era
King, J. T., Justice, A. C., Roberts, M. S., Chang, C.-C. H., & Fusco, J. S. (2003) · Medical Decision Making · doi:10.1177/0272989x02239652 · Cited by 77
Brønnum‐Hansen, H., & Juel, K. (2001) · Tobacco Control · doi:10.1136/tc.10.3.273 · Cited by 73
Phillips, A. N., Leen, C. L. S., Wilson, A., Anderson, J., Dunn, D. T., Schwenk, A., Orkin, C. M., Hill, T., Fisher, M., Walsh, J. C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61815-7 · Cited by 66
Self-citationLong-term trends in adherence to antiretroviral therapy from start of HAART
Cambiano, V., Lampe, F. C., Rodger, A. J., Smith, C. J., Geretti, A. M., Lodwick, R. K., Puradiredja, D. I., Johnson, M. A., Swaden, L., & Phillips, A. N. (2010) · AIDS · doi:10.1097/qad.0b013e32833847af · Cited by 58
Self-citationLampe, F. C., Smith, C. J., Madge, S., Loes, S. K.-D., Tyrer, M., Sabin, C. A., Chaloner, C., Youle, M., Johnson, M. A., & Phillips, A. N. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.692 · Cited by 43
Self-citationStability of antiretroviral regimens in patients with viral suppression
Lodwick, R. K., Smith, C. J., Youle, M. S., Lampe, F. C., Tyrer, M., Bhagani, S. R., Chaloner, C., Sabin, C. A., Johnson, M. A., & Phillips, A. N. (2008) · AIDS · doi:10.1097/qad.0b013e3282fec415 · Cited by 42
Self-citationThe UK Collaborative Group on HIV Drug Resistance and UK CHIC Study Group (2010) · Clinical Infectious Diseases · doi:10.1086/651684 · Cited by 40
Phillips, A. N., Sabin, C. A., Pillay, D., & Lundgren, J. D. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00507.x · Cited by 38
Self-citationTrends over calendar time in antiretroviral treatment success and failure in HIV clinic populations*
Bansi‐Matharu, L., Sabin, C. A., Delpech, V., Hill, T., Fisher, M., Walsh, J. C., Chadborn, T., Easterbrook, P., Gilson, R. J. C., Johnson, M. A., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00809.x · Cited by 35
Self-citationCardiovascular Risk Assessment in Antiretroviral-Naïve HIV Patients
Maggi, P., Quirino, T., Ricci, E. D., Socio, G. V. D., Gadaleta, A., Ingrassia, F., Perilli, F., Lillo, A., & Bonfanti, P. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2009.0102 · Cited by 27
Cited by
Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P., Kowalska, J. D., de Wit, S., Law, M., el Sadr, W., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60604-8 · Cited by 928
Self-citationMay, M. T., Gompels, M., Delpech, V., Porter, K., Orkin, C., Kegg, S., Hay, P., Johnson, M., Palfreeman, A., Gilson, R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000243 · Cited by 593
Self-citationJohnson, L. F., Mossong, J., Dorrington, R. E., Schomaker, M., Hoffmann, C. J., Keiser, O., Fox, M. P., Wood, R., Prozesky, H., Giddy, J., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001418 · Cited by 437
Ray, A. S., Fordyce, M. W., & Hitchcock, M. J. M. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.009 · Cited by 392
Life expectancy living with HIV: recent estimates and future implications
Nakagawa, F., May, M., & Phillips, A. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32835ba6b1 · Cited by 373
Self-citation
Metadata
- Authors
- Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N.
- Venue
- AIDS
- Published
- 2012-01-28
- Volume
- 26
- Issue
- 3
- Pages
- 335-343
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2073853087
- Cited by
- 443
- References
- 44
- FWCI
- 24.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.